BTSG241220P22500
- 3.40
- 0.000.00%
BrightSpring Health Services Newsroom
BrightSpring Health Svcs Is Maintained at Overweight by Wells Fargo
Wells Fargo Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $21
Express News | Brightspring Health Services, Inc. : Wells Fargo Raises Target Price to $21 From $17
Wells Fargo Gives a Buy Rating to BrightSpring Health Services, Inc. (BTSG)
BrightSpring Health Services Announces Onco360 Has Been Selected as a Partner for Several New Drugs
BrightSpring Health Services, Inc. to Participate in Two Upcoming Investor Conferences
BrightSpring Health Services, Inc. Just Missed Earnings; Here's What Analysts Are Forecasting Now
Deutsche Bank Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Raises Target Price to $20
BrightSpring Health Svcs Is Maintained at Outperform by Mizuho
BrightSpring Health Analyst Ratings
Morgan Stanley Maintains BrightSpring Health Services(BTSG.US) With Buy Rating, Maintains Target Price $19
Deutsche Bank Adjusts BrightSpring Health Services Price Target to $20 From $13, Maintains Buy Rating
BrightSpring Health Services: Strong Third-Quarter Performance and Positive Outlook Justify Buy Rating
Express News | Brightspring Health Services Inc : Mizuho Raises Target Price to $20 From $17
BrightSpring Health Services, Inc. (BTSG) Q3 2024 Earnings Call Transcript Summary
Many Still Looking Away From BrightSpring Health Services, Inc. (NASDAQ:BTSG)
10-Q: Q3 2024 Earnings Report
BrightSpring Health Swings to Q3 Adjusted Profit as Revenue Climbs; Raises 2024 Revenue Guidance
8-K: BrightSpring Health Services, Inc. Reports Third Quarter 2024 Financial Results and Increases Full Year 2024 Guidance
BrightSpring Health Raises FY2024 Sales Guidance From $10.45B-10.90B to $11.00B-11.30B (Est $10.831B)